Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
synthetic somatostatin analog |
| gptkbp:approvalYear |
2012
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
H01CB05
|
| gptkbp:brand |
gptkb:Signifor
Signifor LAR |
| gptkbp:CASNumber |
396091-73-9
|
| gptkbp:developer |
gptkb:Novartis
|
| gptkbp:hasMolecularFormula |
C58H66N10O9S2
|
| https://www.w3.org/2000/01/rdf-schema#label |
pasireotide
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
somatostatin receptor agonist
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2103837
DB06663 16025147 |
| gptkbp:routeOfAdministration |
intramuscular injection
subcutaneous injection |
| gptkbp:sideEffect |
gptkb:diabetes_mellitus
bradycardia hyperglycemia gastrointestinal disturbances cholelithiasis |
| gptkbp:synonym |
SOM230
|
| gptkbp:target |
somatostatin receptor subtype 1
somatostatin receptor subtype 2 somatostatin receptor subtype 3 somatostatin receptor subtype 5 |
| gptkbp:UNII |
KJX2KB8W1B
|
| gptkbp:usedFor |
gptkb:Cushing's_disease
acromegaly |
| gptkbp:bfsParent |
gptkb:Signifor
|
| gptkbp:bfsLayer |
6
|